Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 6/20 | 0.31 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RAD52 | P43351 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5086429 | 0.88 | PTGS2 (0.33) | PTGS2ALOX5FUT7HTR2AMEN1 | |
| SCHEMBL3675811 | 0.76 | NR3C1 (0.31) | — | |
| SCHEMBL5089995 | 0.74 | CNR1 (0.33) | MEN1MAPTMAPK1HTTRAD52 | |
| SCHEMBL3684161 | 0.73 | PTGS2 (0.34) | PTGS2ALOX5 | |
| SCHEMBL3673412 | 0.72 | — | — | |
| SCHEMBL5086548 | 0.72 | PTGS2 (0.41) | PTGS2ALOX5HTR2A | |
| SCHEMBL3676188 | 0.69 | ALDH1A1 (0.30) | — | |
| SCHEMBL3684932 | 0.69 | CA1 (0.34) | — | |
| SCHEMBL3689193 | 0.69 | — | — | |
| SCHEMBL3678867 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2045254-B1 | RARE EARTH METAL COMPLEX, CATALYST FOR POLYMERIZATION AND PROCESS FOR PRODUCING POLYMER | SUMITOMO CHEMICAL CO (JP) | 2013-01-09 | — | — | EP | disclosed |
| US-7851569-B2 | Rare earth metal complex, polymerization catalyst, and process for producing polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-12-14 | — | — | US | disclosed |
| US-20090253875-A1 | RARE EARTH METAL COMPLEX, POLYMERIZATION CATALYST AND METHOD FOR PRODUCING POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-10-08 | — | — | US | disclosed |
| EP-2045254-A1 | RARE EARTH METAL COMPLEX, CATALYST FOR POLYMERIZATION AND PROCESS FOR PRODUCING POLYMER | Sumitomo Chemical Company, Limited (JP) | 2009-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253875-A1 | RARE EARTH METAL COMPLEX, POLYMERIZATION CATALYST AND METHOD FOR PRODUCING POLYMER | RPS27L, LAS1L, AGL | PTGS2 3714/4885ALOX5 640/4885FUT7 1833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.